| Literature DB >> 36014906 |
Fenghua Sun1, Agatha Yi-Sum Siu1, Kangle Wang1, Borui Zhang1, Man-Him Chan1, Ka-Hon Chan1, Pui-Sze Kong1, Kei-Yee Man1, Gary Chi-Ching Chow1.
Abstract
This study aimed to investigate the effects of caffeine on performances of simulated match, Wingate Anaerobic Test (WAnT), and cognitive function test of elite taekwondo athletes. Ten elite taekwondo athletes in Hong Kong volunteered to participate in two main trials in a randomized double-blinded crossover design. In each main trial, 1 h after consuming a drink with caffeine (CAF) or a placebo drink without caffeine (PLA), the participants completed two simulated taekwondo match sessions followed by the WAnT. The participants were instructed to complete three cognitive function tests, namely the Eriksen Flanker Test (EFT), Stroop Test, and Rapid Visual Information Processing Test, at baseline, before exercise, and immediately after the simulated matches. They were also required to wear functional near-infrared spectroscopy equipment during these tests. Before exercise, the reaction time in the EFT was shorter in the CAF trial than in the PLA trial (PLA: 494.9 ± 49.2 ms vs. CAF: 467.9 ± 38.0 ms, p = 0.035). In the WAnT, caffeine intake increased the peak power and mean power per unit of body weight (by approximately 13% and 6%, respectively, p = 0.018 & 0.042). The performance in the simulated matches was not affected by caffeine intake (p = 0.168). In conclusion, caffeine intake enhances anaerobic power and may improve certain cognitive functions of elite taekwondo athletes in Hong Kong. However, this may not be enough to improve the simulated match performance.Entities:
Keywords: anaerobic capacity; caffeine; exercise performance; fNIRS; reaction time; taekwondo
Mesh:
Substances:
Year: 2022 PMID: 36014906 PMCID: PMC9414007 DOI: 10.3390/nu14163398
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Illustration of experimental protocol.
Figure 2Optodes position of fNIRS device. 1–8 are channel numbers.
Results of stimulated matches score and performance of the WAnT.
| PLA | CAF | ||
|---|---|---|---|
|
| |||
| Mean score of stimulated matches | 16.6 ± 6.9 | 18.8 ± 9.0 | 0.474 |
| Winning rate (%) | 40.0 ± 0.5 | 60.0 ± 0.5 | 0.168 |
|
| |||
| Peak Power (W) | 1006.0 ± 366.8 | 1114.1 ± 325.2 ** | 0.007 |
| Mean Power (W) | 527.3 ± 152.7 | 551.2 ± 146.2 | 0.071 |
| Peak Power/BW (W/kg) | 14.6 ± 3.5 | 16.5 ± 2.7 * | 0.018 |
| Mean Power/BW (W/kg) | 7.7 ± 1.2 | 8.2 ± 10.0 * | 0.042 |
| Rate of fatigue (%) | 67.9 ± 11.5 | 70.6 ± 4.7 | 0.386 |
| Time to Peak Power (s) | 1.4 ± 0.4 | 1.2 ± 0.2 | 0.055 |
Note. Data are presented as means ± SD. PLA = Placebo trial; CAF = Caffeine trial; WAnT = Wingate Test. * Significantly different from PLA and CAF (p < 0.05). ** Significantly different from PLA and CAF (p < 0.01).
Results of accuracy and reaction time of cognitive function test.
| Cognitive | T0 | T1 | T3 | |||
|---|---|---|---|---|---|---|
| PLA | CAF | PLA | CAF | PLA | CAF | |
|
| ||||||
| EFT | 99.0 ± 1.2 | 98.0 ± 3.1 | 98.0 ± 2.1 | 97.7 ± 3.0 | 99.0 ± 1.3 | 98.3 ± 2.2 |
| ST | 96.5 ± 2.5 | 96.3 ± 4.1 | 98.0 ± 3.7 | 96.8 ± 2.1 | 97.0 ± 3.0 | 96.7 ± 3.6 |
| RVIPT | 52.7 ± 9.5 | 52.4 ± 18.0 | 56.5 ± 16.3 | 61.0 ± 17.4 | 63.4 ± 16.1 | 65.7 ± 22.0 |
|
| ||||||
| EFT | 487.0 ± 63.1 | 494.1 ± 53.1 | 494.9 ± 49.2 | 467.9 ± 38.0 *,a | 484.1 ± 55.6 | 465.4 ± 35.3 * |
| ST | 871.3 ± 109.1 | 809.7 ± 101.4 | 811.9 ± 134.2 | 777.3 ± 102.8 * | 778.6 ± 120.3 * | 743.1 ± 146.8 # |
| RVIPT | 2021.8 ± 953.5 | 2404.1 ± 1811.3 | 1696.5 ± 867.7 | 1847.8 ± 1362.2 | 1749.6 ± 1393.1 | 1572.5 ± 1213.0 |
Note. Data are presented as means ± SD. Measurements were taken baseline (T0), before exercise (T1), and immediately after the simulated match session (T3). PLA = Placebo trial; CAF = Caffeine trial; EFT = Eriksen Flanker Test; ST = Stroop Test; RVIPT = Rapid Visual Information Processing Test. * Significant time differences from EFT-CAF trial: T0 vs. T1; T0 vs. T3. ST-CAF trial: T0 vs. T1; PLA trial: T0 vs. T3 (p < 0.05). # Marginal significant time differences from ST-CAF trial: T0 vs. T3 (p = 0.051). a Significantly different from PLA and CAF at EFT-T1 (p < 0.05).
Figure 3Results of fNIRS data in the left and right PFC at different time points. (A) Flank Test; (B) Stroop Test; (C) RVIP Test. PFC = Prefrontal cortex; PLA: Placebo trial; CAF: Caffeine trial; * Significant difference between PLA trial and CAF trial.
Figure 4Results of blood lactate, RPE, and VAS-MP at different time points. (A) Blood lactate; (B) RPE; (C) VAS-MP. RPE = Rating of perceived exertion; VAS-MP = Visual Analogue Scale for muscles pain. * Significantly different between different time points (p < 0.05).
Results of heart rate.
| T0 | T1 | T2 | T3 | T4 | |
|---|---|---|---|---|---|
| PLA | 80 ± 11 | 82 ± 7 | 182 ± 7 a,b,c | 183 ± 7 a,b,c | 173 ± 8 a,b |
| CAF | 86 ± 16 | 86 ± 15 | 176 ± 16 a,b | 178 ± 18 a,b | 171 ± 10 a,b |
Note. Data are presented as means ± SD. Measurements were taken at different time points. PLA = Placebo trial; CAF = Caffeine trial. a Significantly different from T0 (p < 0.05). b Significantly different from T1 (p < 0.05). c Significantly different from T4 (p < 0.05).